{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:57:49Z","timestamp":1787241469305,"version":"build-2736575974"},"reference-count":126,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Analytical Chemistry"],"DOI":"10.1080\/10408347.2025.2573125","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:58:26Z","timestamp":1760680706000},"page":"1-29","source":"Crossref","is-referenced-by-count":9,"title":["The Analytical Evolution of Glibenclamide (Glyburide) Antidiabetic Agents: Analytical Tools, Challenges, and Future Trends"],"prefix":"10.1080","author":[{"given":"Hemn A. H.","family":"Barzani","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Science, College of Health Science, Lebanese French University","place":["Erbil, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebaz","family":"Anwar Omer","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Sciences and Health, Koya University","place":["Koya 44023, Kurdistan Region \u2013 F.R. Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalamala Ibrahim","family":"Salih Barzani","sequence":"additional","affiliation":[{"name":"Department of Nursing, Mergasor Technical Institute, Erbil Polytechnic University","place":["Erbil 44001, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seerwan Hamadameen","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, College of Health Science, Lebanese French University","place":["Erbil, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshyar Saadi","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Science, Van Yuzuncu Yil University","place":["Van 65080, Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"e_1_3_2_2_1","first-page":"1","article-title":"Introduction to Diabetes Mellitus","volume":"2","author":"Kaul K.","year":"2013","unstructured":"Kaul, K.; Tarr, J. M.; Ahmad, S. I.; Kohner, E. M.; Chibber, R. Introduction to Diabetes Mellitus. Diabetes Old Disease New Insig. 2013, 2, 1\u201311.","journal-title":"Diabetes Old Disease New Insig."},{"key":"e_1_3_2_3_1","first-page":"1099","volume-title":"Textbook of Clinical Medicine","author":"Kumar P.","year":"2002","unstructured":"Kumar, P.; Clark, M. Textbook of Clinical Medicine; Saunders: London, 2002; pp 1099\u20131121."},{"key":"e_1_3_2_4_1","first-page":"254","article-title":"Sulfonylureas for Treating Type 2 Diabetes Mellitus","volume":"3","author":"Lindberg G.","year":"2004","unstructured":"Lindberg, G.; Lindblad, U.; Melander, A. Sulfonylureas for Treating Type 2 Diabetes Mellitus. Cochrane Database System. Rev. 2004, 3, 254.","journal-title":"Cochrane Database System. Rev."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53480-4.00015-1"},{"key":"e_1_3_2_6_1","article-title":"Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance","author":"Zimmet P.","year":"2003","unstructured":"Zimmet, P.; Cowie, C.; Ekoe, J. M.; Shaw, J. Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance. Int. Textbook Diabetes Mellit. 2003.","journal-title":"Int. Textbook Diabetes Mellit."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12232"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3625"},{"key":"e_1_3_2_9_1","first-page":"46","article-title":"Analytical Techniques for the Determination of Metformin and Its Combinations with Oral Antidiabetic Agents in Pharmaceutical Dosage Forms: Combinations with Sulphonylurea Antidiabetic Drugs","volume":"14","author":"Abu Reid I. O.","year":"2024","unstructured":"Abu Reid, I. O.; Osman, S. M.; Bakheet, S. M. Analytical Techniques for the Determination of Metformin and Its Combinations with Oral Antidiabetic Agents in Pharmaceutical Dosage Forms: Combinations with Sulphonylurea Antidiabetic Drugs. J. Drug Deliv. Therap. 2024, 14, 46\u201358.","journal-title":"J. Drug Deliv. Therap."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S426671"},{"key":"e_1_3_2_11_1","first-page":"563","article-title":"Effect of Umbelliferone on Pharmacokinetic and Pharmacodynamic Parameters of Glibenclamide in Streptozocin Induced Diabetic Rats","volume":"8","author":"Malathy P. S.","year":"2024","unstructured":"Malathy, P. S.; Reddy, Y. N. Effect of Umbelliferone on Pharmacokinetic and Pharmacodynamic Parameters of Glibenclamide in Streptozocin Induced Diabetic Rats. Trop. J. Nat. Prod. Res. 2024, 8, 563\u2013568.","journal-title":"Trop. J. Nat. Prod. Res."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20876"},{"key":"e_1_3_2_13_1","first-page":"2","article-title":"Design and Validation of Stability Indicating Assay of Glibenclamide Using RP-HPLC Technique in Both Bulk, Pharmaceutical Formulations and Human Plasma","volume":"9","author":"El-Adl S.","year":"2017","unstructured":"El-Adl, S.; El-Sadek, M.; Hasan, M. Design and Validation of Stability Indicating Assay of Glibenclamide Using RP-HPLC Technique in Both Bulk, Pharmaceutical Formulations and Human Plasma. J. Appl. Pharm. 2017, 9, 2.","journal-title":"J. Appl. Pharm."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2019.03.038"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2020.00099.2"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","unstructured":"Pranita J.; Agrawal R.; Chambhare N.; Ay S. Development and Validation of a Stability-Indicating RP-HPLC Method for Estimation of Glibenclamidei Bulk and Pharmaceutical Formulation. 2023.","DOI":"10.25258\/ijddt.13.3.17"},{"key":"e_1_3_2_17_1","unstructured":"Sv S. Comparative Pharmacokinetics of Sparfloxacin in Glibenclamide Treated and Untreated Diabetic Rats; College of Veterinary and Animal Sciences: Pookode Wayanad 2019."},{"key":"e_1_3_2_18_1","first-page":"337","volume-title":"Analytical Profiles of Drug Substances","author":"Takla P. G.","year":"1981","unstructured":"Takla, P. G. Glibenclamide. In Analytical Profiles of Drug Substances; Elsevier, New York, USA, 1981; Vol. 10, pp 337\u2013355."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160615084752"},{"key":"e_1_3_2_20_1","first-page":"153","article-title":"Pharmacokinetic Studies of Metformin and Glibenclamide in Normal Human Volunteers","volume":"27","author":"Rashid A.","year":"2014","unstructured":"Rashid, A.; Ahmad, M.; Minhas, M. U.; Hassan, I. J.; Malik, M. Z. Pharmacokinetic Studies of Metformin and Glibenclamide in Normal Human Volunteers. Pak. J. Pharm. Sci. 2014, 27, 153\u2013159.","journal-title":"Pak. J. Pharm. Sci."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S102674"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.2c02642"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2023.117437"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202300571"},{"key":"e_1_3_2_25_1","first-page":"863","article-title":"Rapid Analysis of Glibenclamide Using an Environmentally Benign Stability-Indicating RP-HPLC Method","volume":"13","author":"Haq N.","year":"2014","unstructured":"Haq, N.; Alanazi, F. K.; Alsarra, I. A.; Shakeel, F. Rapid Analysis of Glibenclamide Using an Environmentally Benign Stability-Indicating RP-HPLC Method. Iran. J. Pharm. Res. 2014, 13, 863\u2013872.","journal-title":"Iran. J. Pharm. Res."},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.30574\/ijsra.2024.12.1.1108","article-title":"Analytical Techniques for Peptide-Based Drug Development: Characterization, Stability, and Quality Control","volume":"12","author":"Patel N. A.","year":"2024","unstructured":"Patel, N. A.; Patel, N. R. Analytical Techniques for Peptide-Based Drug Development: Characterization, Stability, and Quality Control. Int. J. Sci. Res. Arch. 2024, 12, 3140\u20133159.","journal-title":"Int. J. Sci. Res. Arch."},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf083"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1201\/9781003486909-4","volume-title":"Diagnostic Advances in Precision Medicine and Drug Development","author":"Shaik S.","year":"2025","unstructured":"Shaik, S.; Verma, R.; Kumar, L.; Shirodkar, R. K. High-Performance Liquid Chromatography: Usefulness in Medicine and Therapeutics. In Diagnostic Advances in Precision Medicine and Drug Development; CRC Press, 2025; pp 36\u201348."},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167107"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2023.122714"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2014.01.001"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2018.01.020"},{"key":"e_1_3_2_33_1","first-page":"1","article-title":"Principles and Practice of Chromatography","author":"Scott R. P.","year":"2003","unstructured":"Scott, R. P. Principles and Practice of Chromatography. Chrom-ed Book Series. 2003, 1.","journal-title":"Chrom-ed Book Series."},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202100593"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bfopcu.2016.10.002"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450.2020.1772290"},{"key":"e_1_3_2_37_1","first-page":"119","article-title":"Validation of a New High Performance Liquid Chromatography Assay for Glibenclamide in Human Plasma","volume":"34","author":"Yusuf A.","year":"2009","unstructured":"Yusuf, A.; Hammami, M. Validation of a New High Performance Liquid Chromatography Assay for Glibenclamide in Human Plasma. J. Pharm. Sci. 2009, 34, 119\u2013125.","journal-title":"J. Pharm. Sci."},{"key":"e_1_3_2_38_1","unstructured":"Anitha K.; Kalyankar T.; Ingale V.; Gingine A. P. Simultaneous Determination of Metformin and Glibenclamide in Pharmaceutical Preparation by Rp-Hplc. 2019."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.6000\/1929-5634.2012.01.02.7"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1556\/AChrom.27.2015.3.3"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2007.07.025"},{"key":"e_1_3_2_42_1","first-page":"1","article-title":"Estimation Glibeniclamide Drugs in Bulk and Pharmaceuticalusing Rphplc Method","volume":"7","author":"Srinivas A.","year":"2024","unstructured":"Srinivas, A.; Jhansi, K. Estimation Glibeniclamide Drugs in Bulk and Pharmaceuticalusing Rphplc Method. J. Innov. Develop. Pharm. Techn. Sci. (JIDPTS). 2024, 7, 1\u20138.","journal-title":"J. Innov. Develop. Pharm. Techn. Sci. (JIDPTS)."},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10337-023-04292-x"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.30574\/gscbps.2024.28.1.0267","article-title":"Formulation and Physicotechnical Evaluation of a Fixed Dose Combination of Amlodipine, Metformin and Glibenclamide in the Management of Hypertension-Diabetes Mellitus Comorbidity","volume":"28","author":"Onwuzuligbo C. C.","year":"2024","unstructured":"Onwuzuligbo, C. C.; Onwuzuligbo, A. U.; Akubude, S.; Obika, C.; Obi, D.; Esimone, C.; Emeje, M. Formulation and Physicotechnical Evaluation of a Fixed Dose Combination of Amlodipine, Metformin and Glibenclamide in the Management of Hypertension-Diabetes Mellitus Comorbidity. GSC Biol. Pharm. Sci. 2024, 28, 192\u2013205.","journal-title":"GSC Biol. Pharm. Sci."},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2004.12.018"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.09.005"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/00032719408006368"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826076.2010.532704"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoac\/93.1.133"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.13005\/ojc\/380405"},{"key":"e_1_3_2_51_1","first-page":"593","article-title":"Development and Validation of RP-HPLCMethod for Determination of Glibenclamide in Pharmaceutical Dosage Forms","volume":"4","author":"Jayanthi M.","year":"2012","unstructured":"Jayanthi, M. Development and Validation of RP-HPLCMethod for Determination of Glibenclamide in Pharmaceutical Dosage Forms. Int. J. Chemtech. Res. 2012, 4, 593\u2013601.","journal-title":"Int. J. Chemtech. Res."},{"key":"e_1_3_2_52_1","first-page":"201","article-title":"A Novel Extractionless Hplc Fluorescence Method for the Determination of Glyburide in the Human Plasma: Application to a Bioequivalence Study","volume":"4","author":"Khatri J.","year":"2001","unstructured":"Khatri, J.; Qassim, S.; Abed, O.; Abraham, B.; Al-Lami, A.; Masood, S. A Novel Extractionless Hplc Fluorescence Method for the Determination of Glyburide in the Human Plasma: Application to a Bioequivalence Study. J. Pharm. Pharm. Sci. 2001, 4, 201\u2013206.","journal-title":"J. Pharm. Pharm. Sci."},{"key":"e_1_3_2_53_1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.9734\/IRJPAC\/2014\/10301","article-title":"Development and Validation of Stability Indicating HPLC Method for Simultaneous Determination of Antidiabetic Drugs Metformin Hydrochloride and Glyburide in Tablets","volume":"4","author":"Sakur A.","year":"2014","unstructured":"Sakur, A.; Kudemati, M. Development and Validation of Stability Indicating HPLC Method for Simultaneous Determination of Antidiabetic Drugs Metformin Hydrochloride and Glyburide in Tablets. Int. J. Pure Appl. Chem. 2014, 4, 605\u2013620.","journal-title":"Int. J. Pure Appl. Chem."},{"key":"e_1_3_2_54_1","unstructured":"Wais M.; Sharma A. K.; Aqil M. Development and Validation of Rp-Hplc Method for Estimation of Glibenclamide in Nanoemulsion Formulation. 2015."},{"key":"e_1_3_2_55_1","unstructured":"Wais M.; Sharma A. K.; Aqil M.; Rathore D. S. A Validated Hplc Method for the Estiation of Glibenclamide Nanoemulsion Formulation in Rat Plasma: A Pharmacokinetic Studies. 2015."},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2012.11.037"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2569027"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/10934529.2021.1873671"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0731-7085(02)00013-4"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2016.02.011"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.21608\/rpbs.2022.141915.1148"},{"key":"e_1_3_2_62_1","first-page":"319","article-title":"RP-HPLC Method for the Quantification and in-Vitro Studies of Low Dose Oral Hypoglycemic Tablets","volume":"25","author":"Alnukkary Y.","year":"2014","unstructured":"Alnukkary, Y.; Haidar, S.; Khayat, A. RP-HPLC Method for the Quantification and in-Vitro Studies of Low Dose Oral Hypoglycemic Tablets. Int. J. Pharm. Sci. Rev. Res. 2014, 25, 319\u2013325.","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(91)80084-p"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.04.032"},{"key":"e_1_3_2_65_1","first-page":"1209","article-title":"Single and High Resolution RP-HPLC Method for the Determination of Six anti Diabetic Drug Products","volume":"4","author":"Mallu U. R.","year":"2011","unstructured":"Mallu, U. R.; Pyreddy, V. R.; Penumajji, S.; Bobbarala, V. Single and High Resolution RP-HPLC Method for the Determination of Six anti Diabetic Drug Products. J. Pharm. Res. 2011, 4, 1209\u20131212.","journal-title":"J. Pharm. Res."},{"key":"e_1_3_2_66_1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jaoac\/91.4.709","article-title":"Ultraviolet-Photodiode Array and High-Performance Liquid Chromatographic\/Mass Spectrometric Studies on Forced Degradation Behavior of Glibenclamide and Development of a Validated Stability-Indicating Method","volume":"91","author":"Bansal G.","year":"2008","unstructured":"Bansal, G.; Singh, M.; Jindal, K. C.; Singh, S. Ultraviolet-Photodiode Array and High-Performance Liquid Chromatographic\/Mass Spectrometric Studies on Forced Degradation Behavior of Glibenclamide and Development of a Validated Stability-Indicating Method. J. AOAC Int. 2008, 91, 709\u2013719.","journal-title":"J. AOAC Int."},{"key":"e_1_3_2_67_1","first-page":"125","article-title":"RP-HPLC Method Development and Validation for Estimation of Glibenclamide in Tablet Dosage Form","volume":"4","author":"Narmada D.","year":"2014","unstructured":"Narmada, D.; Krishna, P.; Yusuf, S. M.; Ranganayakulu, B.; Praveen, K. U.; Abhilash, P. R. RP-HPLC Method Development and Validation for Estimation of Glibenclamide in Tablet Dosage Form. Asian J. Pharm. Anal. 2014, 4, 125\u2013128.","journal-title":"Asian J. Pharm. Anal."},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.2174\/2210681212666220816142200"},{"key":"e_1_3_2_69_1","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4172\/2161-1009.1000130","article-title":"Method Development and Validation of Metformine, Pioglitazone and Glibenclamide in Tablet Dosage Form by Using RP-HPLC","volume":"2","author":"Tengli A. R.","year":"2013","unstructured":"Tengli, A. R.; Gurupadayya, B.; Soni, N.; Vishwanathan, B. Method Development and Validation of Metformine, Pioglitazone and Glibenclamide in Tablet Dosage Form by Using RP-HPLC. Biochem. Anal. Biochem. 2013, 2, 2161\u20131009.1000130.","journal-title":"Biochem. Anal. Biochem."},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.39436"},{"key":"e_1_3_2_71_1","first-page":"716","article-title":"Determination of Glibenclamide and Metformin Hydrochloride in Active Pharmaceutical Ingredients and Combined Dosage Form Using a Stability-Indicating HPLC-UV Method","volume":"6","author":"Elrefay H.","year":"2013","unstructured":"Elrefay, H.; Ismaiel, O. A.; Hassan, W. S.; Shalaby, A. Determination of Glibenclamide and Metformin Hydrochloride in Active Pharmaceutical Ingredients and Combined Dosage Form Using a Stability-Indicating HPLC-UV Method. Asian J. Res. Chem. 2013, 6, 716\u2013721.","journal-title":"Asian J. Res. Chem."},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diamond.2025.111995"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diamond.2022.109647"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.5599\/admet.2357"},{"key":"e_1_3_2_75_1","volume-title":"Electrochemical Methods: Fundamentals and Applications","author":"Bard A. J.","year":"2022","unstructured":"Bard, A. J.; Faulkner, L. R.; White, H. S. Electrochemical Methods: Fundamentals and Applications; John Wiley & Sons, Hoboken, NJ, USA, 2022."},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2025.2511141"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/open.201500042"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diamond.2022.109658"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5659.2017.00003.0"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-003-2392-1"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10847-010-9801-9"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.20964\/2020.09.49"},{"key":"e_1_3_2_83_1","unstructured":"\u0627\u0644\u062e\u0648\u0631\u064a \u0645. \u062a\u062d\u062f\u064a\u062f. \u0627\u0644\u063a\u0644\u064a\u0628\u0648\u0631\u064a\u062f. \u0641\u064a. \u0627\u0644\u0645\u0633\u062a\u062d\u0636\u0631\u0627\u062a. \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629. \u0628\u0627\u0644\u0637\u0631\u064a\u0642\u0629. \u0627\u0644\u0641\u0648\u0644\u062a. \u0623\u0645\u0628\u064a\u0631\u0648\u0645\u062a\u0631\u064a\u0629. \u0627\u0644\u062d\u0644\u0642\u064a\u0629. \u0641\u064a. \u0627\u0644\u0648\u0633\u0637\u064a\u0646. \u0627\u0644\u0645\u0639\u062a\u062f\u0644. \u0648\u0627\u0644\u0642\u0644\u0648\u064a. \u0639\u0644\u0649. \u0627\u0644\u0643\u062a\u0631\u0648\u062f. \u0627\u0644\u0630\u0647\u0628. \u0633\u0644\u0633\u0644\u0629 \u0627\u0644\u0639\u0644\u0648\u0645 \u0627\u0644\u0623\u0633\u0627\u0633\u064a\u0629 2024 46 (9)."},{"key":"e_1_3_2_84_1","unstructured":"\u0627\u0644\u062e\u0648\u0631\u064a. \u0645. \u0627\u0644\u062a\u062d\u0644\u064a\u0644 \u0627\u0644\u0641\u0648\u0644\u062a \u0623\u0645\u0628\u064a\u0631\u0648\u0645\u062a\u0631\u064a \u0627\u0644\u062d\u0644\u0642\u064a \u0644\u063a\u0644\u064a\u0628\u0648\u0631\u064a\u062f \u0641\u064a \u0645\u0633\u062a\u062d\u0636\u0631\u0627\u062a\u0647\u0627 \u0627\u0644\u0635\u064a\u062f\u0644\u0627\u0646\u064a\u0629. \u0633\u0644\u0633\u0644\u0629 \u0627\u0644\u0639\u0644\u0648\u0645 \u0627\u0644\u0623\u0633\u0627\u0633\u064a\u0629 2024 46 (13)."},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11164-019-03993-z"},{"key":"e_1_3_2_86_1","first-page":"2013","article-title":"Quantification and Pharmacokinetic Studies for the Anti-Hyperglycemic Drug Glibenclamide Using Stripping Voltammetric Method: Development and Validation","volume":"64","author":"El-Attar M.","year":"2021","unstructured":"El-Attar, M.; Ghoneim.; M.; Electro-Reduction. Quantification and Pharmacokinetic Studies for the Anti-Hyperglycemic Drug Glibenclamide Using Stripping Voltammetric Method: Development and Validation. Egypt. J. Chem. 2021, 64, 2013\u20132024.","journal-title":"Egypt. J. Chem."},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2019.111141"},{"key":"e_1_3_2_88_1","first-page":"356","article-title":"Development of UV Spectrometric Method of Glibenclamide (Glyburide) in Bulk and Pharmaceutical Formulations","volume":"4","author":"Eapen C.","year":"2012","unstructured":"Eapen, C.; Prasanth, V.; Rai, A. Development of UV Spectrometric Method of Glibenclamide (Glyburide) in Bulk and Pharmaceutical Formulations. Int. J. Chemtech Res. 2012, 4, 356\u2013360.","journal-title":"Int. J. Chemtech Res."},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.2116\/analsci.27.1037"},{"key":"e_1_3_2_90_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-12-815499-1.00007-7","volume-title":"Contemporary Practice in Clinical Chemistry","author":"Bachmann L. M.","year":"2020","unstructured":"Bachmann, L. M.; Miller, W. G. Spectrophotometry. In Contemporary Practice in Clinical Chemistry; Elsevier, 2020; pp 119\u2013133."},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470089941.et0201s11"},{"key":"e_1_3_2_92_1","first-page":"14","article-title":"Extractive Spectrophotometric Method for the Determination of Glibenclamide by Ion-Pair Complex in Pure Form and Pharmaceutical Formulation","volume":"10","author":"Mahmood R. M.","year":"2019","unstructured":"Mahmood, R. M.; Yassen, H. M.; Darweesh, S. A.; Issac, N. Extractive Spectrophotometric Method for the Determination of Glibenclamide by Ion-Pair Complex in Pure Form and Pharmaceutical Formulation. Methods. 2019, 10, 14.","journal-title":"Methods."},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.36490\/journal-jps.com.v7i3.545"},{"key":"e_1_3_2_94_1","unstructured":"Dey S.; Samal H. B.; Vaidanathan S.; Ch R.; Srikanth M.; Mohapatro S.; Patnaik A.; Das I. J.; Samanta T. Method Development and Validation for the Estimation of Glibenclamide in Bulk and Pharmaceutical Dosage Forms Using UV-Vis Spectrophotometric Method. 2011."},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.38124\/ijisrt\/25jun709"},{"key":"e_1_3_2_96_1","first-page":"468","article-title":"Development of Glibenclamide Validation Method Using UV-Spectrophotometry for Solubility Test in Mesoporous Mannitol","volume":"19","author":"Kusumorini N.","unstructured":"Kusumorini, N.; Adhyatmika, A.; Biruni, S. I.; Anugrahanti, S. Development of Glibenclamide Validation Method Using UV-Spectrophotometry for Solubility Test in Mesoporous Mannitol. Majalah Farmaseutik. 19, 468\u2013473.","journal-title":"Majalah Farmaseutik."},{"key":"e_1_3_2_97_1","first-page":"316","article-title":"Development and Validation of UV Spectrophotometric Method of Glibenclamide (Glyburide) in Bulk and Pharmaceutical Formulation","volume":"3","author":"Harikrishnan N.","year":"2010","unstructured":"Harikrishnan, N.; Muralikrishna, U.; Shaik, B.; Bhavsar, V.; Kumar, V. R. Development and Validation of UV Spectrophotometric Method of Glibenclamide (Glyburide) in Bulk and Pharmaceutical Formulation. Asian J. Res. Chem. 2010, 3, 316\u2013318.","journal-title":"Asian J. Res. Chem."},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.5958\/2231-5675.2016.00012.0"},{"key":"e_1_3_2_99_1","first-page":"173","article-title":"Microemulsion-Based Strategy for the Capillary Electrophoretic Analysis of Some Antidiabetic Drugs","volume":"25","author":"Am\u0103riu\u0163ei I.","year":"2015","unstructured":"Am\u0103riu\u0163ei, I.; Florea, M.; Ghica, M. V.; Popa, L.; Monciu, C.-M.; Ilie, M. Microemulsion-Based Strategy for the Capillary Electrophoretic Analysis of Some Antidiabetic Drugs. Romanian J. Biophys. 2015, 25, 173\u2013184.","journal-title":"Romanian J. Biophys."},{"key":"e_1_3_2_100_1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/clinchem\/46.11.1773","article-title":"Comparison of Capillary Electrophoresis with HPLC for Diagnosis of Factitious Hypoglycemia","volume":"46","author":"Paroni R.","year":"2000","unstructured":"Paroni, R.; Comuzzi, B.; Arcelloni, C.; Brocco, S.; De Kreutzenberg, S.; Tiengo, A.; Ciucci, A.; Beck-Peccoz, P.; Genovese, S. Comparison of Capillary Electrophoresis with HPLC for Diagnosis of Factitious Hypoglycemia. Clin. Chem. 2000, 46, 1773\u20131780.","journal-title":"Clin. Chem."},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.05.030"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-015-8921-x"},{"key":"e_1_3_2_103_1","first-page":"44","article-title":"Determination of Pka Values of Antidiabetic Drugs from Mobility Data and Pharmaceutical Analysis by Capillary Electrophoresis","author":"Sanli S.","year":"2022","unstructured":"Sanli, S.; Sardogan, S.; \u00d6zdemir, A.; Atalay, B. Determination of Pka Values of Antidiabetic Drugs from Mobility Data and Pharmaceutical Analysis by Capillary Electrophoresis. J. Chem. Soc. Pak. 2022, 44.","journal-title":"J. Chem. Soc. Pak."},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1039\/c3ay26263d"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.v5.1.53"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.21608\/aprh.2022.168998.1199"},{"key":"e_1_3_2_107_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2710.1989.tb00236.x","article-title":"A Rapid High\u2010Performance Liquid Chromatography Assay of Glibenclamide in Serum","volume":"14","author":"Abdel\u2010Hamid M.","year":"1989","unstructured":"Abdel\u2010Hamid, M.; Suleiman, M.; El\u2010Sayed, Y.; Najib, N.; Hasan, M. A Rapid High\u2010Performance Liquid Chromatography Assay of Glibenclamide in Serum. J. Clin. Pharm. Ther. 1989, 14, 181\u2013188.","journal-title":"J. Clin. Pharm. Ther."},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3314"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2007.06.003"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29204834"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1080\/02772248.2013.777603"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2023.101199"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70128"},{"key":"e_1_3_2_114_1","first-page":"337","article-title":"Dissolution Enhancement of Glibenclamide by Solid Dispersion: Solvent Evaporation versus a Supercritical Fluid-Based Solvent-Antisolvent Technique","volume":"9","author":"Tabbakhian M.","year":"2014","unstructured":"Tabbakhian, M.; Hasanzadeh, F.; Tavakoli, N.; Jamshidian, Z. Dissolution Enhancement of Glibenclamide by Solid Dispersion: Solvent Evaporation versus a Supercritical Fluid-Based Solvent-Antisolvent Technique. Res. Pharm. Sci. 2014, 9, 337\u2013350.","journal-title":"Res. Pharm. Sci."},{"key":"e_1_3_2_115_1","first-page":"175","article-title":"Enhancing Dissolution, Serum Concentrations and Hypoglycemic Effect of Glibenclamide Using Solvent Deposition Technique","volume":"8","author":"Dastmalchi S.","year":"2005","unstructured":"Dastmalchi, S.; Garjani, A.; Maleki, N.; Sheikhee, G.; Baghchevan, V.; Jafari-Azad, P.; Valizadeh, H.; Barzegar-Jalali, M. Enhancing Dissolution, Serum Concentrations and Hypoglycemic Effect of Glibenclamide Using Solvent Deposition Technique. J. Pharm. Pharm. Sci. 2005, 8, 175\u2013181.","journal-title":"J. Pharm. Pharm. Sci."},{"key":"e_1_3_2_116_1","first-page":"1","article-title":"World Journal Medical & Pharmaceutical Research","volume":"1","author":"Dugaje T.","year":"2025","unstructured":"Dugaje, T.; Akbari, B. World Journal Medical & Pharmaceutical Research. World. 2025, 1, 1\u201322.","journal-title":"World."},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.4314\/jopat.v24i1.30"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1177\/20552076231203879"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2023.116951"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2019.111360"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc5300"},{"key":"e_1_3_2_122_1","first-page":"192","article-title":"AI in Chemistry: The Future of Scientific Discovery","author":"Silas N.","year":"2024","unstructured":"Silas, N. AI in Chemistry: The Future of Scientific Discovery. Sci. Spect. AI Enhan. Future. 2024, 192.","journal-title":"Sci. Spect. AI Enhan. Future."},{"key":"e_1_3_2_123_1","volume-title":"The Theory and Practice Of Green Analytical Chemistry","author":"Stumpf C.","unstructured":"Stumpf, C. The Theory and Practice Of Green Analytical Chemistry. The White Paper."},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1039\/b926439f"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.5937\/jomb0-45936"},{"key":"e_1_3_2_126_1","doi-asserted-by":"crossref","DOI":"10.1039\/9781839168864","volume-title":"Green Analytical Chemistry.","author":"Koel M.","year":"2019","unstructured":"Koel, M.; Kaljurand, M. Green Analytical Chemistry. 2nd ed.; Royal Society of Chemistry, Cambridge, UK, 2019.","edition":"2"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.3390\/jsan14010006"}],"container-title":["Critical Reviews in Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408347.2025.2573125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:58:36Z","timestamp":1760680716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408347.2025.2573125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":126,"alternative-id":["10.1080\/10408347.2025.2573125"],"URL":"https:\/\/doi.org\/10.1080\/10408347.2025.2573125","relation":{},"ISSN":["1040-8347","1547-6510"],"issn-type":[{"value":"1040-8347","type":"print"},{"value":"1547-6510","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}